FindMyKOL

Meghan Berkenstock, MD

Basic profile

Johns Hopkins University

ORCID↗NPI↗
✓ Itemized record
RegionBel Air, MD · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLEmergingFindMyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Meghan Berkenstock is an Ophthalmology physician affiliated with Johns Hopkins University. OpenAlex indexes 116 publications with 1,219 citations (h-index 16).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
116publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,219citations

Total citations across indexed works.

16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
13companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    65.2%
    Corticosteroid20.3%
    Prednisolone Acetate100%
    Part D≥160 patients
    Quinolone Antimicrobial13.6%
    Ofloxacin100%
    Part D≥125 patients

    + 5 more classes in this area

  • Musculoskeletal

    15.4%
    Cyclooxygenase Inhibitor15.4%
    Ketorolac Tromethamine100%
    Part D≥127 patients
  • Anti-infectives

    8.2%
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor4.6%
    Valacyclovir100%
    Part D≥25 patients
    Macrolide2.3%
    Erythromycin100%
    Part D≥22 patients

    + 1 more class in this area

Where care is delivered (Part B)12.3% facility · 87.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”